SCHEMBL8909447

SCHEMBL8909447

CC(C)(c1ccccc1)[C@H](CS(=O)(=O)C(C)(C)C)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.40
HIF1A Q16665 1/20 0.40
KIF11 P52732 7/20 0.39
MAPT P10636 2/20 0.37
KMT2A Q03164 1/20 0.37
HSD11B1 P28845 1/20 0.36
KYNU Q16719 2/20 0.36
ALDH1A1 P00352 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
MME P08473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8909445 1.00 CYP2C19 (0.40) CYP2C19HIF1AKIF11MAPTKMT2A
SCHEMBL4377967 0.78 CYP2C19 (0.46) CYP2C19HIF1AKIF11MAPTKMT2A
SCHEMBL9755832 0.76 CYP2C19 (0.48) CYP2C19HIF1AKIF11MAPTKMT2A
SCHEMBL9971684 0.75 CYP2C19 (0.43) CYP2C19HIF1AKIF11MAPTKMT2A
SCHEMBL4378855 0.75 CYP1A2 (0.50) CYP2C19HIF1AMAPTKMT2AALDH1A1
SCHEMBL4375323 0.72 CYP2C19 (0.49) CYP2C19HIF1AKIF11MAPTKMT2A
SCHEMBL7163321 0.71 CYP1A2 (0.59) MMECYP1A2
SCHEMBL7277365 0.71 CYP1A2 (0.59) MMECYP1A2
SCHEMBL7269232 0.71 CYP1A2 (0.59) MMECYP1A2
SCHEMBL12868288 0.70 HRH1 (0.40) CYP2C19CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5688946-A DIPEPTIDES FOR HYPOTENSIVE AGENTS AND CARDIOVASCULAR DISORDERS HOFFMANN LA ROCHE INC. (US) 1997-11-18 US disclosed